← Back to Search

Data-Driven Care Approach for Psychosis (EPI-CAL Trial)

N/A
Waitlist Available
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Must not have
Neurological illness or injury leading to psychotic symptoms
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of study, maximum of 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether a new method of collecting and visualizing data on patients with early psychosis will help create a more effective treatment plan and improve outcomes.

Who is the study for?
This trial is for young people aged 12-30 who've had their first episode of psychosis within the last 5 years and are getting treatment at participating sites. It's also open to family members over age 18, care providers, community stakeholders, and individuals at high risk but without a full-blown psychosis.
What is being tested?
The study aims to create a network in California that uses mobile health tech and clinician dashboards to track patient data on early psychosis. They're testing how well they can collect this data across clinics and developing a tool to measure untreated psychosis duration.
What are the potential side effects?
Since this trial focuses on data collection rather than medication or medical procedures, traditional side effects aren't applicable. However, participants may experience discomfort or privacy concerns related to sharing personal health information.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had a brain condition or injury that caused severe mental health symptoms.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of study, maximum of 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and end of study, maximum of 5 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Colorado Symptom Index (CSI) - Symptom severity
DUP Tool convergent validity
DUP Tool feasibility and Acceptability
+6 more
Secondary study objectives
Provider level factors
Satisfaction with care

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: EPI-CAL mHealth data networkExperimental Treatment1 Intervention
This arm of the study involves the use of the mobile health technology ("app") to measure outcomes within an early psychosis (EP) program.
Group II: DUP EvaluationExperimental Treatment1 Intervention
A subset of individuals will participate in interviews to validate a tool to determine the duration of untreated psychosis in community settings

Find a Location

Who is running the clinical trial?

Washington University School of MedicineOTHER
1,991 Previous Clinical Trials
2,294,555 Total Patients Enrolled
University of California, DavisLead Sponsor
943 Previous Clinical Trials
4,754,359 Total Patients Enrolled
University of California, San FranciscoOTHER
2,586 Previous Clinical Trials
14,898,717 Total Patients Enrolled

Media Library

First Episode Psychosis Research Study Groups: EPI-CAL mHealth data network, DUP Evaluation
~61 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top